AMARIN CORP PLC\UK Class of Warrant or Right, Outstanding
AMARIN CORP PLC\UK (AMRN) had Class of Warrant or Right, Outstanding of 0 shares as of 2017-12-31, per its 10-K filed 2018-02-27.
Discontinued › Notes › Other Liabilities
us-gaap:ClassOfWarrantOrRightOutstanding · last filed 2018-02-27
- 2017-12-31: Class of Warrant or Right, Outstanding 0.00 shares.
- 2016-12-31: Class of Warrant or Right, Outstanding 0.00 shares.
- 2016-09-30: Class of Warrant or Right, Outstanding 0.00 shares.
- 2016-06-30: Class of Warrant or Right, Outstanding 0.00 shares.
| Period end | Class of Warrant or Right, Outstanding |
|---|---|
| 2017-12-31 | 0.00 shares 10-K · filed 2018-02-27 |
| 2016-12-31 | 0.00 shares 10-K · filed 2018-02-27 |
| 2016-09-30 | 0.00 shares 10-Q · filed 2016-11-03 |
| 2016-06-30 | 0.00 shares 10-Q · filed 2016-08-04 |
| 2016-03-31 | 0.00 shares 10-Q · filed 2016-05-05 |
| 2015-12-31 | 0.00 shares 10-K · filed 2016-02-25 |
| 2014-12-31 | 8.09M shares 10-K · filed 2015-03-03 |
| 2014-09-30 | 8.09M shares 10-Q · filed 2014-11-06 |
| 2014-06-30 | 9.77M shares 10-Q · filed 2014-08-07 |
| 2014-03-31 | 9.77M shares 10-Q · filed 2014-05-09 |
| 2013-12-31 | 9.79M shares 10-K · filed 2014-02-27 |
| 2013-09-30 | 9.82M shares 10-Q · filed 2013-11-07 |
| 2013-06-30 | 9.87M shares 10-Q · filed 2013-08-08 |
| 2013-03-31 | 9.87M shares 10-Q · filed 2013-05-09 |
| 2012-12-31 | 9.94M shares 10-K · filed 2013-02-28 |
| 2012-09-30 | 10.22M shares 10-Q · filed 2012-11-08 |
| 2012-06-30 | 11.29M shares 10-Q · filed 2012-08-08 |
| 2012-03-31 | 21.07M shares 10-Q · filed 2012-05-08 |
| 2011-12-31 | 21.11M shares 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B |